Pharmacy

After its rival Pfizer was slammed on Twitter by President Donald Trump for raising the price of several drugs, Swiss pharmaceutical company Novartis announced it will halt drug price increases in the U.S. for the remainder of the year, according…

Swiss pharmaceutical giant Novartis saw its second-quarter net income surge to $7.77 billion, up from $1.98 billion in the second quarter of 2017.

Johnson & Johnson beat revenue and earnings estimates for the second quarter of 2018 as sales of pharmaceuticals surged 20 percent year-over-year, CNBC reports.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety.

Six days after Pfizer announced it would postpone  price hikes, Sen. Tammy Baldwin, D-Wis., sent a letter to the company's CEO Ian Read calling on the pharmaceutical manufacturer to institute permanent price rollbacks, according to The Hill.

The FDA recalled several medications containing valsartan, an active ingredient used to control blood pressure and prevent heart failure, July 13, a week after 22 other countries issued a recall.

In an effort to combat shortages of medically necessary products, the FDA will create the Drug Shortages Task Force, the agency announced July 12.

The FDA issued a warning July 13 to notify consumers who purchase medications online or by phone about a recent scam in which criminals pose as agency officials.

A jury in St. Louis awarded $550 million in actual damages and $4.14 billion in punitive damages in a lawsuit against pharmaceutical giant Johnson & Johnson, claiming its talcum powder caused ovarian cancer, according to the St. Louis Post-Dispatch.

Novartis is shutting down antibacterial and antiviral research at its campus in Emeryville, Calif., which will result in a loss of 140 jobs, according to Bloomberg.